The United States Hereditary Angioedema Therapeutics Market size is a dynamic landscape marked by significant growth potential. Expected to expand at a compound annual growth rate (CAGR) of 8.20% between 2024 and 2032, this market reflects both the increasing prevalence of hereditary angioedema (HAE) and advancements in therapeutic options. This comprehensive guide aims to delve into the...